Chapter/Section Purchase

1 Study Coverage
1.1 Peramivir Product Introduction
1.2 Market by Type
1.2.1 Global Peramivir Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Solution
1.2.3 Solid
1.3 Market by Application
1.3.1 Global Peramivir Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Peramivir Sales Estimates and Forecasts 2017-2028
2.2 Global Peramivir Revenue Estimates and Forecasts 2017-2028
2.3 Global Peramivir Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Peramivir Sales by Region
2.4.1 Global Peramivir Sales by Region (2017-2022)
2.4.2 Global Sales Peramivir by Region (2023-2028)
2.5 Global Peramivir Revenue by Region
2.5.1 Global Peramivir Revenue by Region (2017-2022)
2.5.2 Global Peramivir Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Peramivir Sales by Manufacturers
3.1.1 Global Top Peramivir Manufacturers by Sales (2017-2022)
3.1.2 Global Peramivir Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peramivir in 2021
3.2 Global Peramivir Revenue by Manufacturers
3.2.1 Global Peramivir Revenue by Manufacturers (2017-2022)
3.2.2 Global Peramivir Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Peramivir Revenue in 2021
3.3 Global Peramivir Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Peramivir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Peramivir Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peramivir Sales by Type
4.1.1 Global Peramivir Historical Sales by Type (2017-2022)
4.1.2 Global Peramivir Forecasted Sales by Type (2023-2028)
4.1.3 Global Peramivir Sales Market Share by Type (2017-2028)
4.2 Global Peramivir Revenue by Type
4.2.1 Global Peramivir Historical Revenue by Type (2017-2022)
4.2.2 Global Peramivir Forecasted Revenue by Type (2023-2028)
4.2.3 Global Peramivir Revenue Market Share by Type (2017-2028)
4.3 Global Peramivir Price by Type
4.3.1 Global Peramivir Price by Type (2017-2022)
4.3.2 Global Peramivir Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Peramivir Sales by Application
5.1.1 Global Peramivir Historical Sales by Application (2017-2022)
5.1.2 Global Peramivir Forecasted Sales by Application (2023-2028)
5.1.3 Global Peramivir Sales Market Share by Application (2017-2028)
5.2 Global Peramivir Revenue by Application
5.2.1 Global Peramivir Historical Revenue by Application (2017-2022)
5.2.2 Global Peramivir Forecasted Revenue by Application (2023-2028)
5.2.3 Global Peramivir Revenue Market Share by Application (2017-2028)
5.3 Global Peramivir Price by Application
5.3.1 Global Peramivir Price by Application (2017-2022)
5.3.2 Global Peramivir Price Forecast by Application (2023-2028)
6 North America
6.1 North America Peramivir Market Size by Type
6.1.1 North America Peramivir Sales by Type (2017-2028)
6.1.2 North America Peramivir Revenue by Type (2017-2028)
6.2 North America Peramivir Market Size by Application
6.2.1 North America Peramivir Sales by Application (2017-2028)
6.2.2 North America Peramivir Revenue by Application (2017-2028)
6.3 North America Peramivir Market Size by Country
6.3.1 North America Peramivir Sales by Country (2017-2028)
6.3.2 North America Peramivir Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Peramivir Market Size by Type
7.1.1 Europe Peramivir Sales by Type (2017-2028)
7.1.2 Europe Peramivir Revenue by Type (2017-2028)
7.2 Europe Peramivir Market Size by Application
7.2.1 Europe Peramivir Sales by Application (2017-2028)
7.2.2 Europe Peramivir Revenue by Application (2017-2028)
7.3 Europe Peramivir Market Size by Country
7.3.1 Europe Peramivir Sales by Country (2017-2028)
7.3.2 Europe Peramivir Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Peramivir Market Size by Type
8.1.1 Asia Pacific Peramivir Sales by Type (2017-2028)
8.1.2 Asia Pacific Peramivir Revenue by Type (2017-2028)
8.2 Asia Pacific Peramivir Market Size by Application
8.2.1 Asia Pacific Peramivir Sales by Application (2017-2028)
8.2.2 Asia Pacific Peramivir Revenue by Application (2017-2028)
8.3 Asia Pacific Peramivir Market Size by Region
8.3.1 Asia Pacific Peramivir Sales by Region (2017-2028)
8.3.2 Asia Pacific Peramivir Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Peramivir Market Size by Type
9.1.1 Latin America Peramivir Sales by Type (2017-2028)
9.1.2 Latin America Peramivir Revenue by Type (2017-2028)
9.2 Latin America Peramivir Market Size by Application
9.2.1 Latin America Peramivir Sales by Application (2017-2028)
9.2.2 Latin America Peramivir Revenue by Application (2017-2028)
9.3 Latin America Peramivir Market Size by Country
9.3.1 Latin America Peramivir Sales by Country (2017-2028)
9.3.2 Latin America Peramivir Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Peramivir Market Size by Type
10.1.1 Middle East and Africa Peramivir Sales by Type (2017-2028)
10.1.2 Middle East and Africa Peramivir Revenue by Type (2017-2028)
10.2 Middle East and Africa Peramivir Market Size by Application
10.2.1 Middle East and Africa Peramivir Sales by Application (2017-2028)
10.2.2 Middle East and Africa Peramivir Revenue by Application (2017-2028)
10.3 Middle East and Africa Peramivir Market Size by Country
10.3.1 Middle East and Africa Peramivir Sales by Country (2017-2028)
10.3.2 Middle East and Africa Peramivir Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 BioCryst Pharmaceuticals
11.1.1 BioCryst Pharmaceuticals Corporation Information
11.1.2 BioCryst Pharmaceuticals Overview
11.1.3 BioCryst Pharmaceuticals Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 BioCryst Pharmaceuticals Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BioCryst Pharmaceuticals Recent Developments
11.2 Green Cross Pharma
11.2.1 Green Cross Pharma Corporation Information
11.2.2 Green Cross Pharma Overview
11.2.3 Green Cross Pharma Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Green Cross Pharma Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Green Cross Pharma Recent Developments
11.3 Shionogi Co.
11.3.1 Shionogi Co. Corporation Information
11.3.2 Shionogi Co. Overview
11.3.3 Shionogi Co. Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Shionogi Co. Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shionogi Co. Recent Developments
11.4 NeoPharm
11.4.1 NeoPharm Corporation Information
11.4.2 NeoPharm Overview
11.4.3 NeoPharm Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 NeoPharm Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 NeoPharm Recent Developments
11.5 Moksha8 Pharma
11.5.1 Moksha8 Pharma Corporation Information
11.5.2 Moksha8 Pharma Overview
11.5.3 Moksha8 Pharma Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Moksha8 Pharma Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Moksha8 Pharma Recent Developments
11.6 NT Pharma
11.6.1 NT Pharma Corporation Information
11.6.2 NT Pharma Overview
11.6.3 NT Pharma Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 NT Pharma Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 NT Pharma Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Corporation Information
11.8.2 Hikma Pharmaceuticals Overview
11.8.3 Hikma Pharmaceuticals Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hikma Pharmaceuticals Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hikma Pharmaceuticals Recent Developments
11.9 Hunan Nucien Pharmaceutical Co., Ltd.
11.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Corporation Information
11.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Overview
11.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments
11.10 SCOLR Pharma
11.10.1 SCOLR Pharma Corporation Information
11.10.2 SCOLR Pharma Overview
11.10.3 SCOLR Pharma Peramivir Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 SCOLR Pharma Peramivir Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 SCOLR Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peramivir Industry Chain Analysis
12.2 Peramivir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peramivir Production Mode & Process
12.4 Peramivir Sales and Marketing
12.4.1 Peramivir Sales Channels
12.4.2 Peramivir Distributors
12.5 Peramivir Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Peramivir Industry Trends
13.2 Peramivir Market Drivers
13.3 Peramivir Market Challenges
13.4 Peramivir Market Restraints
14 Key Findings in The Global Peramivir Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer